vs
Astrana Health, Inc.(ASTH)与Regions Financial Corporation(RF)财务数据对比。点击上方公司名可切换其他公司
Regions Financial Corporation的季度营收约是Astrana Health, Inc.的1.3倍($1.3B vs $950.5M),Regions Financial Corporation净利率更高(41.7% vs 0.7%,领先41.0%),Astrana Health, Inc.同比增速更快(42.9% vs 4.1%),过去两年Astrana Health, Inc.的营收复合增速更高(53.3% vs 4.0%)
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商,主要服务全美符合联邦医保资格的老年群体,提供上门初级护理、慢性病管理及护理协调服务,致力于提升患者健康水平、降低不必要的医疗支出。
Regions Financial Corporation是美国银行控股企业,总部位于阿拉巴马州伯明翰市。公司提供零售及商业银行、信托、股票经纪、抵押贷款等服务,旗下银行业务子公司Regions Bank在美国南部和中西部15个州运营约1300家营业网点和2000台自动柜员机,服务大量当地个人及企业客户。
ASTH vs RF — 直观对比
营收规模更大
RF
是对方的1.3倍
$950.5M
营收增速更快
ASTH
高出38.7%
4.1%
净利率更高
RF
高出41.0%
0.7%
两年增速更快
ASTH
近两年复合增速
4.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $950.5M | $1.3B |
| 净利润 | $6.6M | $534.0M |
| 毛利率 | — | — |
| 营业利润率 | 1.9% | 55.3% |
| 净利率 | 0.7% | 41.7% |
| 营收同比 | 42.9% | 4.1% |
| 净利润同比 | 184.4% | 0.0% |
| 每股收益(稀释后) | $0.12 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASTH
RF
| Q4 25 | $950.5M | $1.3B | ||
| Q3 25 | $956.0M | $1.3B | ||
| Q2 25 | $654.8M | $1.3B | ||
| Q1 25 | $620.4M | $1.2B | ||
| Q4 24 | $665.2M | $1.2B | ||
| Q3 24 | $478.7M | $1.2B | ||
| Q2 24 | $486.3M | $1.2B | ||
| Q1 24 | $404.4M | $1.2B |
净利润
ASTH
RF
| Q4 25 | $6.6M | $534.0M | ||
| Q3 25 | $373.0K | $569.0M | ||
| Q2 25 | $9.4M | $563.0M | ||
| Q1 25 | $6.7M | $490.0M | ||
| Q4 24 | $-7.8M | $534.0M | ||
| Q3 24 | $16.1M | $490.0M | ||
| Q2 24 | $19.2M | $501.0M | ||
| Q1 24 | $14.8M | $368.0M |
营业利润率
ASTH
RF
| Q4 25 | 1.9% | 55.3% | ||
| Q3 25 | 2.0% | 56.3% | ||
| Q2 25 | 3.1% | 56.1% | ||
| Q1 25 | 3.3% | 52.0% | ||
| Q4 24 | 0.1% | 53.4% | ||
| Q3 24 | 5.9% | 49.9% | ||
| Q2 24 | 6.2% | 52.7% | ||
| Q1 24 | 7.5% | 39.2% |
净利率
ASTH
RF
| Q4 25 | 0.7% | 41.7% | ||
| Q3 25 | 0.0% | 45.3% | ||
| Q2 25 | 1.4% | 44.7% | ||
| Q1 25 | 1.1% | 41.0% | ||
| Q4 24 | -1.2% | 43.4% | ||
| Q3 24 | 3.4% | 40.2% | ||
| Q2 24 | 3.9% | 42.2% | ||
| Q1 24 | 3.7% | 31.1% |
每股收益(稀释后)
ASTH
RF
| Q4 25 | $0.12 | $0.59 | ||
| Q3 25 | $0.01 | $0.61 | ||
| Q2 25 | $0.19 | $0.59 | ||
| Q1 25 | $0.14 | $0.51 | ||
| Q4 24 | $-0.14 | $0.55 | ||
| Q3 24 | $0.33 | $0.49 | ||
| Q2 24 | $0.40 | $0.52 | ||
| Q1 24 | $0.31 | $0.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | — |
| 总债务越低越好 | — | $4.1B |
| 股东权益账面价值 | $779.3M | $19.0B |
| 总资产 | $2.2B | $158.8B |
| 负债/权益比越低杠杆越低 | — | 0.22× |
8季度趋势,按日历期对齐
现金及短期投资
ASTH
RF
| Q4 25 | $429.5M | — | ||
| Q3 25 | $463.4M | — | ||
| Q2 25 | $342.1M | — | ||
| Q1 25 | $260.9M | — | ||
| Q4 24 | $290.8M | — | ||
| Q3 24 | $350.3M | — | ||
| Q2 24 | $327.7M | — | ||
| Q1 24 | $337.3M | — |
总债务
ASTH
RF
| Q4 25 | — | $4.1B | ||
| Q3 25 | — | $4.8B | ||
| Q2 25 | — | $5.3B | ||
| Q1 25 | — | $6.0B | ||
| Q4 24 | — | $6.0B | ||
| Q3 24 | — | $6.0B | ||
| Q2 24 | — | $5.1B | ||
| Q1 24 | — | $3.3B |
股东权益
ASTH
RF
| Q4 25 | $779.3M | $19.0B | ||
| Q3 25 | $775.5M | $19.0B | ||
| Q2 25 | $765.5M | $18.7B | ||
| Q1 25 | $745.4M | $18.5B | ||
| Q4 24 | $712.7M | $17.9B | ||
| Q3 24 | $704.6M | $18.7B | ||
| Q2 24 | $678.9M | $17.2B | ||
| Q1 24 | $653.5M | $17.0B |
总资产
ASTH
RF
| Q4 25 | $2.2B | $158.8B | ||
| Q3 25 | $2.2B | $159.9B | ||
| Q2 25 | $1.4B | $159.2B | ||
| Q1 25 | $1.3B | $159.8B | ||
| Q4 24 | $1.4B | $157.3B | ||
| Q3 24 | $1.3B | $157.4B | ||
| Q2 24 | $1.3B | $154.1B | ||
| Q1 24 | $1.2B | $154.9B |
负债/权益比
ASTH
RF
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | 0.25× | ||
| Q2 25 | — | 0.28× | ||
| Q1 25 | — | 0.32× | ||
| Q4 24 | — | 0.34× | ||
| Q3 24 | — | 0.32× | ||
| Q2 24 | — | 0.30× | ||
| Q1 24 | — | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $-319.0M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | — |
| 自由现金流率自由现金流/营收 | -0.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | -0.44× | -0.60× |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势,按日历期对齐
经营现金流
ASTH
RF
| Q4 25 | $-2.9M | $-319.0M | ||
| Q3 25 | $10.0M | $861.0M | ||
| Q2 25 | $90.9M | $573.0M | ||
| Q1 25 | $16.6M | $1.1B | ||
| Q4 24 | $-10.9M | $-220.0M | ||
| Q3 24 | $34.0M | $1.3B | ||
| Q2 24 | $23.2M | $161.0M | ||
| Q1 24 | $6.0M | $396.0M |
自由现金流
ASTH
RF
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | — | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | — | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | — | ||
| Q2 24 | $20.4M | — | ||
| Q1 24 | $5.6M | — |
自由现金流率
ASTH
RF
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 1.4% | — |
资本支出强度
ASTH
RF
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.1% | — |
现金转化率
ASTH
RF
| Q4 25 | -0.44× | -0.60× | ||
| Q3 25 | 26.69× | 1.51× | ||
| Q2 25 | 9.65× | 1.02× | ||
| Q1 25 | 2.48× | 2.18× | ||
| Q4 24 | — | -0.41× | ||
| Q3 24 | 2.11× | 2.57× | ||
| Q2 24 | 1.21× | 0.32× | ||
| Q1 24 | 0.40× | 1.08× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
RF
| Consumer Bank | $747.0M | 58% |
| Corporate Bank | $487.0M | 38% |
| Wealth Management | $47.0M | 4% |